- Efficient Targeting and Activation of Antigen-Presenting Cells In Vivo after Modified mRNA Vaccine Administration in Rhesus Macaques.
Efficient Targeting and Activation of Antigen-Presenting Cells In Vivo after Modified mRNA Vaccine Administration in Rhesus Macaques.
Molecular therapy : the journal of the American Society of Gene Therapy (2017-09-30)
Frank Liang, Gustaf Lindgren, Ang Lin, Elizabeth A Thompson, Sebastian Ols, Josefine Röhss, Shinu John, Kimberly Hassett, Olga Yuzhakov, Kapil Bahl, Luis A Brito, Hugh Salter, Giuseppe Ciaramella, Karin Loré
PMID28958578
ABSTRACT
mRNA vaccines are rapidly emerging as a powerful platform for infectious diseases because they are well tolerated, immunogenic, and scalable and are built on precise but adaptable antigen design. We show that two immunizations of modified non-replicating mRNA encoding influenza H10 hemagglutinin (HA) and encapsulated in lipid nanoparticles (LNP) induce protective HA inhibition titers and H10-specific CD4
MATERIALS
Product Number
Brand
Product Description
Pricing and availability is not currently available.
